Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Pembrolizumab for Platinum- and Cetuximab-Refractory Head and Neck Cancer: Results From a Single-Arm, Phase II Study
PaperCitations, authors & open-access status
Pembrolizumab for Platinum- and Cetuximab-Refractory Head and Neck Cancer: Results From a Single-Arm, Phase II Study is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 657 citations, 2017 year and closed oa status.
657
Citations
2017
Year
closed
OA Status